Skip to search formSkip to main contentSkip to account menu

NSC 3051

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

N-methylformamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer
SummaryFifty-four evaluable patients with SCLC previously treated with chemotherapy received either N-methylformamide or… 
1990
1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix
SummaryTwenty patients with advanced measurable, squamous carcinoma of the cervix were treated with 25 courses of N-MF at doses… 
1990
1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group study.
Twenty patients with advanced measurable, squamous carcinoma of the cervix were treated with 25 courses of N-MF at doses ranging… 
1990
1990
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer
SummaryForty-four patients with advanced, measurable, epithelial carcinoma of the ovary were treated with 97 courses of N… 
1986
1986
S-(N-Methylcarbamoyl)-N-acetylcysteine: a urinary metabolite of the hepatotoxic experimental antitumour agent N-methylformamide (NSC 3051) in mouse, rat and man.
1985
1985
Phase I trial of N-methylformamide (NMF, NSC 3051).
N-methylformamide (NMF) is a polar-planar solvent with both cytotoxic and differentiating activity in preclinical models; it also… 
1985
1985
N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapy.
1983
1983
The formation and metabolism of N-hydroxymethyl compounds--IV. Cytotoxicity and antitumour activity of N-hydroxymethylformamide, a putative metabolite of N-methylformamide (NSC 3051).
1982
1982
Pharmacokinetic studies of n-methylformamide (nsc 3051) in mice. Abstr.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)